Company / Shareholders' Equity
SOLENO THERAPEUTICS INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$450.1M
FY2025
5-year range
$10.3M / $450.1M
FY2021-FY2025
Trend
+83.6%
vs FY2024
Sector context
#103 of 215
Health Care
What the data says
At $450M, SOLENO THERAPEUTICS INC's shareholders' equity ranks #103 of 215 in the Health Care sector. Shareholders' Equity has increased for 3 consecutive years, from $10M in FY2022 to $450M in FY2025.
Based on SEC 10-K filings.
$450M in FY2025 with a 5-year CAGR of +58.1%.
Improved from $158M to $450M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +251.7%
- 5-Year CAGR
- +58.1%
- 10-Year CAGR
- -
Sector benchmark
#103 of 215 in Health CareTop 48% of 215This company $450.1M Sector average $2.6B
▼
-82.4% below sector average
Key checks
Key Insights
- SOLENO THERAPEUTICS INC's shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +58.1%, indicating consistent growth.
- In FY2025, shareholders' equity increased 83.6% year-over-year.
- Ranks #103 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $450.1M | +83.6% |
| FY2024 | $245.1M | +55.6% |
| FY2023 | $157.5M | +1422.1% |
| FY2022 | $10.3M | -41.8% |
| FY2021 | $17.8M | -60.9% |
| FY2020 | $45.5M | +204.7% |
| FY2019 | $14.9M | -50.9% |
| FY2018 | $30.4M | +13.4% |
| FY2017 | $26.8M | +680.7% |
| FY2016 | $3.4M | +6.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026